1.610USD+5.92%Mkt Cap: 4.98M $P/E: —2d ago
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worl…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap4.98M $
Enterprise Value3.76M $
Revenue (TTM)4.33M $
Gross Profit498.00K $
Net Income (TTM)-4.97M $
Revenue/Share1.608 USD
Last Price1.610 USD
Fiscal Year EndMay 2025
MR QuarterFeb 2026
Employees53
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)4.06
PEG—
EV/EBITDA-0.71
EV/Revenue0.87
P/S1.13
P/B1.45
EPS (TTM)-1.65
EPS (Forward)0.39
52W Range
1.4507% of range3.600
52W High3.600 USD
52W Low1.450 USD
Profitability
Gross Margin9.38%
Oper. Margin-131.51%
EBITDA Margin-121.75%
Profit Margin-93.64%
ROE-121.14%
ROA-83.65%
Growth
Revenue Growth-11.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.84M $
CapEx (TTM)37.00K $
FCF Margin-46.88%
FCF Yield-40.77%
Net Debt-1.14M $
Net Debt/EBITDA0.22
Balance Sheet
Debt/Equity0.11
Current Ratio2.64
Quick Ratio1.46
Book Value/Sh1.095 USD
Cash/Share0.4320 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:8
Split DateApr 21, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.09M
Float2.77M
Insiders15.24%
Institutions4.05%
Short Interest
Short Ratio3.4d
Short % Float0.84%
Short % Out.0.75%
Shares Short23.05K
Short (prev mo.)32.61K
Technical
SMA 501.690 (-4.7%)
SMA 2002.153 (-25.2%)
Beta0.31
S&P 52W Chg18.16%
Avg Vol (30d)6.24K
Avg Vol (10d)5.08K
Technical Indicators
RSI (14)38.2
MACD-0.0435
MACD Signal-0.0521
MACD Hist.+0.0086
BB Upper1.655 USD
BB Middle1.579 USD
BB Lower1.504 USD
BB Width9.55%
ATR (14)0.0732 USD
Vol Ratio (20d)1.22x